• Indian Indices
  • Global Indices
  • Commodities
  • Currency
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 21-May-2018
-232.17 (-0.67%)
-79.70 (-0.75%)
    No Companies Visited

Back to news list
  • ICICI Prudential Life launches Heart / Cancer Protect

    ICICI Prudential Life launched ICICI Pru Heart / Cancer Protect. The unique feature of this product is that it pays part of the insurance cover amount to the customer on diagnosis of a Heart ailment or Cancer. Thus, the customer gets the necessary financial support and freedom to choose the best available treatment to address the medical condition.

    Even after the payment on diagnosis, the policy continues without the customer having to pay any future premiums.

    Customers have the flexibility to choose the type of cover, either for Heart or Cancer or have the option to purchase both covers.

    Heart ailments and Cancer together account for over 50% of casualties among Indians. Medical research suggests that India has the highest rate of cardiac arrests in the world and it is estimated that 2 lakh heart surgeries are conducted every year. Cancer cases are expected to rise by 25% by 2020. Every 13th new cancer patient is from India.

    Today, with state of the art medical facilities available, both Heart disorders and Cancer can be effectively treated, if detected early and the patient has the required financial resources to get appropriate medical intervention.

    The Heart / Cancer Protect product has been designed to enable customers to meet the costs of treating these conditions. The fact that the payment is made on diagnosis means that the individual has the freedom to choose the right kind of treatment at the right time. It also comes with an add-on benefit called income replacement which provides 1% of the insurance cover as monthly payments to the customer. This will offset any temporary loss of income which an individual may have to face, while undergoing the medical treatment.

    Heart / Cancer Protect also offers customers the option of increasing the amount of cover every year. This feature is meant to help keep pace with the ever rising cost of medical treatment.

    The affordability aspect makes the product attractive. For as low as Rs.100/- per month a customer can get a Cancer cover for Rs.20 lakh or a Heart cover for Rs.10 lakh.

    Mr. Puneet Nanda, Executive Director, said “Protecting Health and Life is crucial for every working individual with responsibilities. While we urge individuals to lead a healthy way of life, stress, a sedentary lifestyle, negligence towards dietary habits etc. are responsible for the growing number of cases of Heart ailments and Cancer.”

    He further added that “The key to fighting these conditions is early detection and timely treatment. Very often patients do not get appropriate or complete treatment due to financial constraints. We do understand the impact of such diseases on the family – both emotionally and financially. The lumpsum payout feature of the Heart / Cancer Protect product gives customers the flexibility to choose the course of treatment they want. The features of this product have been specifically designed to provide customers with the necessary financial resources to win the battle against these ailments. To ensure easy accessibility, the product is available for purchase on our website as well as across all our distribution channels.”

    Back to news list
Previous Stories :
Insurance News

Quick Links

Since 1986, Capital Market Publishers India Pvt Ltd is undertaking equity research, publishing an investment fortnightly magazine, data-vending and software production. Analysts track industry, companies and the economy. Branches in the metros and major cities ensure comprehensive coverage.

The major strength is equity research. Stock-picking for investor’s portfolio is preceded by rigorous research. The advisory services are transmitted through Capital Market magazine, newsletters, Telefolio. Almost 85% of the scrip’s recommended by us show appreciation. On an average we outperform the Bombay Stock Exchange Sensitive Index twice over, and sometime three times. Our independent status insulates us from influence from brokers and other market participants, ensuring that the selection of stocks and research are unbiased.

We are also pioneers in corporate databases - Capitaline, Mutual Fund database - Navindia

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine Print Edition queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 21-May-2018
  •  ( 17:35) Indostar Capital Finance settles at Rs 585.50 on BSE  
  •  ( 16:45) Market drops on broad-based selling  
  •  ( 15:56) Market slides for 5th straight session  
  •  ( 15:07) Kitex Garments Q4 net profit drops 61.53% to Rs 10.33 crore  
  •  ( 10:22) Indostar Capital Finance lists at Rs 600 on BSE  
  •  ( 10:02) Sheela Foam Q4 cons net profit jumps 92.69% to Rs 32.16 cr  
  •  ( 09:47) RBI imposes penalty of Rs 5 crore on South Indian Bank  
  •  ( 08:26) Indiabulls Real Estate approves buyback of equity shares   
  •  ( 08:17) Tata Steel completes acquisition of Bhushan Steel   
  •  ( 08:12) Asian markets rally as US-China trade tensions ease  
Show News
21 May 2018 00:00
(-1.43 %)
(-0.53 %)
(-0.75 %)
(-2.07 %)
(-0.48 %)
(1.26 %)
(-4.23 %)
(-2.00 %)
(-1.04 %)
(-1.87 %)
(-1.57 %)
(1.13 %)
(-0.25 %)
(-0.10 %)
(-0.02 %)
(-1.57 %)
(-0.16 %)
(-0.92 %)
(-0.99 %)
(-1.20 %)
(0.30 %)
(0.14 %)
(-0.16 %)
(2.47 %)
(-4.50 %)
(-2.85 %)
(-2.86 %)
(-2.47 %)
(1.59 %)
(-1.69 %)
(-3.27 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.